Drug-labels.com Search Menu

Alunbrig: Uses, Side Effects and Dosage

Updated:
Facts
Status:
Prescription (Rx)
Strength:
30 mg, 90 mg, 180 mg
Active ingredient:
ATC code:

Patient Medication Information: uses, side effects, how to take - Alunbrig

What is ALUNBRIG used for?

ALUNBRIG is used to treat adults with non-small cell lung cancer (NSCLC) that is caused by a change in the anaplastic lymphoma kinase (ALK) gene (called ALK-positive). These patients will have ALK-positive NSCLC that has grown outside of the lung (called locally advanced) or has spread to other parts of the body (called metastatic). A test is done to find out if there is a change in the ALK-gene.

For these patients, their disease:

  • cannot be cured with surgery or other treatment (like chemotherapy or radiation); and
  • will not have been previously treated.

ALUNBRIG is also used in patients whose cancer has gotten worse after taking crizotinib or in patients who are unable to take crizotinib.

Serious Warnings and Precautions

ALUNBRIG can cause severe side effects which include:

  • Serious lung problems (such as Interstitial Lung Disease or Pneumonitis), which can cause breathing problems, shortness of breath, cough, or fever that may result in death.
  • Hypertension which is high blood pressure
  • Elevation of pancreatic enzymes which is an increase in the levels of amylase or lipase in the blood. This can cause weight loss, nausea or abdominal pain that gets worse with eating.
  • Hyperglycemia which is increased sugar in the blood
  • Creatine phosphokinase (CPK) elevation which means there is a higher than normal level of CPK in the blood. This can cause muscle pain, tenderness or weakness.

ALUNBRIG should only be prescribed by doctors who are experienced in the use of drugs to treat cancer.

How does ALUNBRIG work?

ALUNBRIG may slow or stop the growth of lung cancer if the cancer is caused by a change in a gene called anaplastic lymphoma kinase (ALK). By doing so, ALUNBRIG may slow down the growth and spread of non-small cell lung cancer (NSCLC).

What are the ingredients in ALUNBRIG?

Medicinal ingredients: brigatinib

Non-medicinal ingredients: lactose monohydrate, magnesium stearate, microcrystalline cellulose, silica colloidal hydrophobic, sodium starch glycolate (type A). The tablet coating consists of polyethylene glycol, polyvinyl alcohol, talc and titanium dioxide.

ALUNBRIG comes in the following dosage forms:

Tablets: 30 mg, 90 mg, and 180 mg

Do not use ALUNBRIG if:

  • you are allergic to brigatinib or any of the other ingredients in ALUNBRIG

To help avoid side effects and ensure proper use, talk to your healthcare professional before you take ALUNBRIG. Talk about any health conditions or problems you may have, including if you:

  • have problems with your lungs or problems breathing
  • have problems with your heart including slow heart rate
  • have problems with high blood pressure
  • are taking medicines to lower your blood pressure or control your heart rate
  • have problems with your vision
  • have problems with your muscles including muscle pain, tenderness, or weakness
  • have or have had problems with your pancreas
  • have or have had problems with your kidneys
  • have or have had problems with your liver
  • have diabetes or high blood sugar
  • are pregnant
  • think you may be pregnant
  • you and your partner plan on becoming pregnant
  • are breast-feeding or plan to breast-feed
  • are younger than 18 years of age. The effects of ALUNBRIG in people younger than 18 years old are not known
  • are intolerant to lactose, as ALUNBRIG contains lactose.

Tell your healthcare professional immediately if, during your treatment with ALUNBRIG, you experience any new or worsening symptoms as follows:

  • Cough with or without mucous, fever, chest pain, trouble breathing or shortness of breath, especially in the first week of treatment. These may be signs of serious lung problems.
  • Slowing of your heart rate, severe headache, or if you feel dizzy, lightheaded, or faint during

    • treatment. These may be signs of heart or blood pressure problems.
  • Weight loss or nausea, or abdominal pain that gets worse with eating and may spread to the back. These may be signs of problems with your pancreas.
  • You become very thirsty or urinate frequently. These may be signs of a high level of sugar in the blood.
  • Unexplained muscle pain or muscle pain that does not go away, tenderness or weakness. These may be signs of muscle problems.
  • Pain on the right side of your stomach area, yellowing of your skin or the whites of your eyes, or dark urine. These may be signs of problems with your liver.
  • Blurred vision, seeing double, have difficultly seeing in bright light, see flashes of light or loss of vision. These may be signs of eye problems.

Other warnings you should know about:

  • ALUNBRIG should only be used by people whose lung cancer is caused by a change in a gene called anaplastic lymphoma kinase (ALK). Before you start taking ALUNBRIG, you should have had your cancer tested for this change.
  • Do not drive or use machines or tools if you feel tired or dizzy or have problems with your vision while taking ALUNBRIG.

  • ALUNBRIG can cause your skin to become very sensitive to sunlight. You should avoid prolonged exposure to the sun or tanning beds while you are taking ALUNBRIG and for 5 days after your last dose. When you are in the sun, wear protective clothing, a hat, a broad spectrum UVA/UVB sunscreen and lip balm with a Sun Protection Factor (SPF) of at least 30. These will, protect against sunburn.

Fertility in men

ALUNBRIG may lower fertility in men. Talk to your healthcare professional if you are planning to father a child in the future.

Pregnancy and breast-feeding

  • Pregnant women

    ALUNBRIG may harm an unborn baby. You must tell your healthcare professional if you are or think you may be pregnant. Ask your healthcare professional for advice if you are planning to have a baby.

  • Breast-feeding mothers

    Do not use ALUNBRIG while breast feeding and for at least 1 week after stopping treatment.

Birth control in men and women

  • Women

    During your ALUNBRIG treatment, do not become pregnant. Use a highly effective, non hormonal birth control method, during treatment and for 4 months after stopping ALUNBRIG. Hormonal forms of birth control such as oral contraceptives (birth control pills)

    may not be effective if used during treatment with ALUNBRIG. Talk to your healthcare professional for advice on effective methods of birth control.

  • Men

    Do not father a child during your ALUNBRIG treatment and for 3 months after stopping treatment. Use condoms if you have sex while receiving ALUNBRIG and for 3 months after stopping treatment.

Tell your healthcare professional about all the medicines you take, including any drugs, vitamins, minerals, natural supplements or alternative medicines.

The following may interact with ALUNBRIG:

  • ketoconazole, itraconazole, voriconazole, fluconazole: medicines to treat fungal infections
  • efavirenz, etravirine, indinavir, nelfinavir, ritonavir, saquinavir, cobicistat: medicines to treat HIV infection
  • boceprevir, telaprevir: medicines to treat hepatitis C infection
  • clarithromycin, nafcillin, telithromycin, troleandomycin, ciprofloxacin, erythromycin: medicines to treat bacterial infections
  • bosentan, diltiazem, verapamil: medicines to treat irregular heart rhythm and high blood pressure
  • drugs that lower heart rate: antiarrhythmics, beta adrenoceptor antagonists, non-dihydropyridine calcium channel blockers, digitalis glycosides, cholinesterase inhibitors, sphingosine-1 phosphate receptor modulators, alpha2-adrenoceptor agonists, and If blockers
  • nefazodone: a medicine to treat depression
  • St. John’s wort: an herbal product used to treat depression. It is also known as hypericum perforatum.
  • ergot alkaloids: medicines used to treat throbbing headaches, such as migraines and cluster headaches
  • fentanyl: a medicine to treat pain
  • modafinil: a medicine to treat excessive sleepiness
  • carbamazepine: a medicine to treat epilepsy, euphoric/depressive episodes and certain pain conditions
  • phenobarbital, phenytoin: medicines to treat epilepsy
  • pimozide: a medicine to treat schizophrenia
  • quetiapine: a medicine to treat schizophrenia, bipolar disorder, and depression
  • rifabutin, rifampicin: medicines to treat tuberculosis or certain other infections
  • digoxin: a medicine to treat heart weakness
  • dabigatran: a medicine to inhibit blood clotting
  • colchicine: a medicine to treat gout attacks
  • cisapride: a medicine to treat heartburn
  • pravastatin, rosuvastatin, simvastatin: medicines to lower cholesterol levels
  • methotrexate: a medicine to treat severe joint inflammation, cancer, and the skin disease

    • psoriasis
  • sulfasalazine: a medicine to treat severe bowel and rheumatic joint inflammation
  • cyclosporine: a medicine to treat severe bowel and joint inflammation, and the skin disease psoriasis
  • sirolimus, tacrolimus: medicines used after an organ transplant
  • metformin: a medicine to treat diabetes
  • estrogen, progestogen: hormonal birth control such as the pill, the patch, hormone-containing intrauterine device, or vaginal ring.
  • grapefruit and grapefruit juice

How to take ALUNBRIG:

  • Always take ALUNBRIG exactly as your doctor or pharmacist has told you. Check with your healthcare professional if you are not sure.
  • ALUNBRIG is taken by mouth. Swallow each tablet whole with water. Do not crush or chew the tablets.
  • ALUNBRIG may be taken with or without food.

Usual dose:

  • Take the 90 mg tablet of ALUNBRIG once a day for the first 7 days of treatment. Then take the 180 mg tablet once a day.
  • If you are taking certain medications or are feeling unwell, your doctor may:

    • start you on a different dose
    • lower your dose
    • stop your treatment for a short time, or
    • stop your treatment completely

Overdose:

If you think you, or a person you are caring for, have taken too much ALUNBRIG, contact a healthcare professional, hospital emergency department, or regional poison control centre immediately, even if there are no symptoms.

Missed Dose:

If you forget to take ALUNBRIG:

  • Take your next dose at your regular time
  • Do not take a double dose to make up for your missed dose

Vomiting:

  • If you vomit (throw up) after taking ALUNBRIG, do not take an extra dose of ALUNBRIG. Just take your next dose at the usual time.

What are possible side effects from using ALUNBRIG?

These are not all the possible side effects you may have when taking ALUNBRIG. If you experience any side effects not listed here, tell your healthcare professional.

  • Abdominal pain also called abdominal discomfort, nausea, vomiting, diarrhea, constipation, acid reflux
  • Cold-like symptoms
  • Dry mouth
  • Inflammation of the mouth, lips and other mucous membranes
  • Indigestion
  • Decreased appetite
  • Taste disturbance
  • Rash
  • Acne or pimples
  • Dry skin
  • Itchy skin
  • Skin sensitivity to the sun
  • Muscle spasms
  • Muscle and/or bone stiffness
  • Pain including joint, muscle, chest, abdomen and pain in back, arms and legs
  • Fatigue
  • Weakness
  • Swelling caused by excess fluid
  • Cough
  • Shortness of breath
  • Headache
  • Dizziness
  • Trouble sleeping
  • Depression
  • Impairment or change in voice quality
  • Fever
  • Numbness and tingling in the hands and feet
  • Weight gain

Your healthcare professional will conduct tests before you start taking ALUNBRIG and regularly during your treatment. These tests will include measurements of your blood pressure and heart rate. You will also have blood tests. ALUNBRIG can cause abnormal blood test results. Your healthcare professional will decide when to perform blood tests and will interpret the results. These results will tell your healthcare professional how ALUNBRIG is affecting your muscles, liver and pancreas.

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
VERY COMMON
Hypertension (high blood pressure): headaches, dizziness, blurred vision, chest pain or shortness of breath√
Increased blood levels of amylase or lipase: weight loss or nausea, or abdominal pain that gets worse with eating and may spread to the back√
Increased blood levels of aspartate aminotransferase (AST) and alanine aminotransferase (ALT): pain on the right side of your stomach area, yellowing of your skin or the whites of your eyes, or dark urine√
Increased blood level of creatine phosphokinase: unexplained muscle pain, tenderness or weakness√
Hyperglycemia (increased blood sugar): frequent urination, thirst, and hunger√
Serious Lung Problems (such as pneumonia, pneumonitis, interstitial lung disease): new or worsening difficulty breathing, chest pain, shortness of breath, cough with or without mucous, or fever√
Vision Problems: loss or change in vision√

Anemia (decrease in number of red

blood cells): dizziness, feeling tired and weak, loss of energy, shortness of breath

√
Neutropenia (decrease in number of white blood cells): aches, feeling tired, fever, flu-like symptoms, infections√
Lymphopenia (decrease in number of lymphocytes): infections√
Nausea√
Vomiting√

Serious side effects and what to do about them

Symptom / effectTalk to your healthcare professionalStop taking drug and get immediate medical help
Only if severeIn all cases
Diarrhea: loose or watery and frequent stools√
COMMON
Pyrexia: fever√
Bradycardia (slow heartbeat): chest pain or discomfort, changes in heartbeat, dizziness, light-headedness or fainting√
Stomatitis: mouth sores√

If you have a troublesome symptom or side effect that is not listed here or becomes bad enough to interfere with your daily activities, tell your healthcare professional.

Reporting Side Effects

You can report any suspected side effects associated with the use of health products to Health Canada by:

  • Visiting the Web page on Adverse Reaction Reporting (https://www.canada.ca/en/health-canada/services/drugs-health-products/medeffect-canada.html) for information on how to report online, by mail or by fax; or
  • Calling toll-free at 1-866-234-2345.

NOTE: Contact your health professional if you need information about how to manage your side effects. The Canada Vigilance Program does not provide medical advice.

Storage:

Store ALUNBRIG between 15-30°C

Keep out of reach and sight of children.

If you want more information about ALUNBRIG:

  • Talk to your healthcare professional
  • Find the full product monograph that is prepared for healthcare professionals and includes this Patient Medication Information by visiting the Health Canada website: (https://www.canada.ca/en/health-canada/services/drugs-health-products/drug-products/drug-product-database.html; the manufacturer’s website http://www.takeda.com/en-ca/alunbrigpm, or by calling 1-800-268-2772.

ALUNBRIG® and the ALUNBRIG Logo® are registered trademarks of ARIAD Pharmaceuticals, Inc.

TAKEDA™ and the TAKEDA Logo® are trademarks of Takeda Pharmaceutical Company Limited, used under license.

Last Revised: July 19, 2022

About this document

Source: Health Canada – Drug Product Database (DPD) and product monographs · DIN (Drug Identification Number): 02479206

Revision date stated in the text: July 19, 2022

Found a mistake? Write to us via the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Drug information for Alunbrig

Rx or OTC
Prescription (Rx)?
DIN 02479206, 02479214, 02479222
Schedule(s) PRESCRIPTION
Active ingredient(s) Brigatinib
Dosage form(s) Tablet
Route(s) of administration Oral
Drug class (WHO ATC)
  1. L Antineoplastic and immunomodulating agents
    1. L01 Antineoplastic agents
      1. L01E Protein kinase inhibitors, antineoplastic and immunomodulating agents
        1. L01ED Anaplastic lymphoma kinase (ALK) inhibitors
          1. L01ED04 Brigatinib
Company TAKEDA CANADA INC
Current status Marketed
Current status date August 31, 2018
Strengths and forms
DIN Strength Dosage form(s) Current status
02479206 30 MG Tablet Marketed August 31, 2018
02479214 90 MG Tablet Marketed August 31, 2018
02479222 180 MG Tablet Marketed August 31, 2018

Source: Health Canada – Drug Product Database (DPD) and product monographs, data as of November 12, 2026. Data from the Health Canada Drug Product Database, as published there. Not a substitute for the advice of a doctor or pharmacist.